Related Experiment Video
Updated: Aug 15, 2026

Biochemical Titration of Glycogen In vitro
Published on: November 24, 2013
Hemoglobin variants and determination of glycated hemoglobin (HbA1c)
W J Schnedl1, A Liebminger, R E Roller
1Department of Internal Medicine, Karl-Franzens University School of Medicine, Auenbruggerplatz 15, A-8036 Graz, Austria. wolfgang.schnedl@kfunigraz.ac.at
Insights
Glycated hemoglobin (HbA1c) testing is crucial for diabetes management. However, hemoglobin variants can interfere, leading to inaccurate HbA1c results and potentially affecting patient care.
Area of Science:
- Clinical Chemistry
- Endocrinology
- Hematology
Background:
- Glycated hemoglobin (GHb) measurement is vital for assessing long-term glycemic control in diabetic patients.
- Studies like DCCT and UKPDS confirm the link between glycemic control and diabetes complications.
- Current testing excludes samples with hemoglobinopathies, lacking guidelines for Hb variants.
Purpose of the Study:
- To review how hemoglobin variants interfere with glycated hemoglobin assays.
- To highlight the potential for false HbA1c results due to these interferences.
Main Methods:
- Literature review of studies on glycated hemoglobin determination.
- Analysis of interference mechanisms of hemoglobin variants on HbA1c assays.
Main Results:
- Hemoglobin variants are known to interfere with various glycated hemoglobin determination methods.
- This interference can lead to inaccurate HbA1c values, misrepresenting glycemic control.
Conclusions:
- The presence of hemoglobin variants poses a significant challenge for accurate HbA1c measurement.
- Standardized guidelines are needed to address the comparability of samples with Hb variants to ensure reliable diabetes management.
Abstract:
Measurement of glycated hemoglobin in diabetic patients is an established procedure for evaluating long-term control of diabetes. The Diabetes Control and Complications Trial (DCCT), as well as the United Kingdom Prospective Diabetes Study (UKPDS), confirmed the direct relationship between the degree of glycemic control as estimated by glycohemoglobin (GHb) determinations and the development and progression of long-term complications in diabetic patients. Samples with known interferences of HbA(1c) determination as hemoglobinopathies are specifically excluded from certification testing and there are no guidelines or requirements for comparability of samples containing hemoglobin (Hb) variants. This paper reviews the interference of Hb variants on determination methods of glycated hemoglobin as they result in false HbA(1c) results.
More Related Videos
Related Concept Videos
Multiple Allele Traits
Blood Types
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...
Hemoglobin
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
Blood Typing
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target antigens A,...
Oxygen Transport in the Blood
Hyperglycemia

